{"url_path":"/sec/mbot/8-k/2026-07-21/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-21","source_url":"https://www.sec.gov/Archives/edgar/data/883975/0001493152-26-034014-index.html","accession_number":"0001493152-26-034014","cik":"0000883975","ticker":"MBOT","issuer_name":"Microbot Medical Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/883975/0001493152-26-034014-index.html","primary_entity_key":"0000883975","primary_entity_name":"Microbot Medical Inc."},"word_count":171,"has_tables":true,"body_markdown":"** **\n\n**Item\n7.01 Regulation FD Disclosure.**\n\n \n\nOn\nJuly 21, 2026, Microbot Medical Inc. (the “Company”) issued a press release announcing that Harel Gadot, the Company’s\nCEO, President and Chairman, will be participating at this year’s Society of Robotic Surgery (SRS) annual meeting, being held from\nJuly 23-26, 2026, in Fort Lauderdale, FL. He will present an overview of the endovascular robotic market and discuss emerging technologies\nin the peripheral vascular, neurovascular and cardiovascular spaces.\n\n \n\nThe\npanel will be livestreamed at 10:25 am ET at:\n\nhttps://srs2026.eventscribe.net/SearchByBucket.asp?pfp=Track&bm=Plenary+3%3A+Novel+Robotic+Technologies+and+Applications+in+Digital+Surgery.\n\n \n\nThe\npress release is furnished as Exhibit 99.1 to this Current Report on Form 8-K, and is incorporated herein by reference. The information\nin this Item 7.01 and Exhibit 99.1 is being furnished and shall not be deemed to be “filed” for the purposes of Section 18\nof the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. This report will not be\ndeemed an admission as to the materiality of any information in this Item 7.01 or Exhibit 99.1."}